NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
PROTEINA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROTEINA
ST13
US500000097655467Class
9, 10, 42, 44
Filing
97655467
Registration
7700523
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
02/25/2025
Trademark type
Word
Nice classes
9, 10, 42, 44
Filing date
10/31/2022
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
08/05/2015
First use in commerce
12/16/2020
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
HENRY, NAKIA D
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Proteina Co., Ltd.
Representatives
Hun Joon Kim LEX IP MEISTER, PLLC.
Technical classification
Nice Classes
Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Biochip for research or scientific purposes; Biochip analyzing apparatusoptical imaging apparatus and instruments in conjunction with biochip for use in the study of proteinspeptidesDNAaptamerRNAnot for medical purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devicesbio-cell chips for research or scientific purposes; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devicesscientific apparatus and instruments for analyzing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presenceabsencequantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteinspeptidesDNAaptamerRNAnot for medical purposes; Biosensorssensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteinsDNAcellsnot for medical purpose; Downloadable and recorded computer software for use in database generationanalysismanagement; Downloadable and recorded computer software for use in optical image and scientific data analysis; Downloadable images in the field of in vitro diagnosticsnamely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes; Downloadable images in the field of in vitro diagnosticsnamely fluorescence images used for in vitro diagnostics
Class 10
Analyzers for analyzing immunological activity for medical purposes; Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic usefor medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materialsproteinscells relevant to diseases; Medical instruments for analyzing and identifying genomic materialsproteinscells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Apparatus for medicalclinicaldiagnostic uses by analyzing genomic materialsproteinscells related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a conditionnamely genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materialsproteinscells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materialsproteinsbio-samples for medical purposes; Apparatus for testing genomic materialsproteinscells relevant to diseases for medical purposes; Medical apparatus for testing genomic materialsproteinscells relevant to diseasesnamely cancer and inflammatory disease; Apparatus for analyzing images for medical usefluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materialsproteinsbio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals
Class 42
Conducting early evaluation of new pharmaceutical compounds in development by others; Discovery and development of new drug candidate material; Scientific research for medical purposes in the area of cancerous diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical product evaluationtechnical assessment of the efficiency of pharmaceuticals; Medical research laboratory services for predicting disease; Pharmaceutical testing; Pharmaceutical research services; Provision of information regarding testinginspectionresearch of pharmaceutical products; Pharmaceutical product evaluation; Scientific research into medicinehealthpharmacology; Human tissue analysis for the purpose of medical research; Design of devices intended for protein analysis; Protein analysis; Development of devices intended for protein analysis; Scientific and technological servicesscientific research in the field of biopharmaceuticals; Development of medical diagnostic instruments; Technological research in the field of biopharmaceuticals; Technical data analysis services for genomic and proteomic materials; Materials analysis; Development of computer software for big data processing; Biomedical research services; Biological research; Pharmaceutical research and development; Medical and scientific researchconducting clinical trials by proxy; Medical and scientific researchconducting clinical studies of medicines for others; Pharmaceutical product evaluation; Scientific research services for medical purposes; Design of medical diagnostic apparatus and instruments; Development of computer software for use with medical equipment; Laboratory research services relating to pharmaceuticals; Design and development of image processing software; Medical analysis services relevant to drug developmentlaboratory testingscientific research; Providing medical and scientific research information services relating to pharmaceuticals and medical products in the fields of pharmaceuticals and genetics; Medical laboratory services for the analysis of samples taken from patients
Class 44
Medical analysis for the diagnosis and treatment of persons; Medical analysis services for cancer diagnosis and prognosis; Provision of information regarding cancer preventionscreeningdiagnosistreatment; Medical analysis services relating to cancer diagnoses; Analysis of human biometric data for medical purposes; Medical analysis services relevant to diagnoses; Medical information services relating to pharmaceuticals and medical products; Providing information services relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals for pharmaceuticals and medical products; Medical diagnostic services for testing and analysis; Analysis of human tissue for medical treatment; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Clinical medical consultation servicescollectingreviewinganalyzingreporting clinical data; Medical analysis services relating to treatment of patients
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/27/2024
IUAA
USE AMENDMENT ACCEPTED
11/27/2024
ALIE
ASSIGNED TO LIE
08/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/20/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/20/2024
IUAF
USE AMENDMENT FILED
02/20/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/20/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/20/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2023
GNRT
NON-FINAL ACTION E-MAILED
08/21/2023
CNRT
NON-FINAL ACTION WRITTEN
08/21/2023
DOCK
ASSIGNED TO EXAMINER
08/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2022
NWAP
NEW APPLICATION ENTERED
11/03/2022
Continuous trademark protection
Get notified about every new filing that threatens PROTEINA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.